tiprankstipranks
Trending News
More News >
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (HK:2502)
:2502
Hong Kong Market
Advertisement

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) AI Stock Analysis

Compare
0 Followers

Top Page

HK:2502

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H

(2502)

Rating:61Neutral
Price Target:
HK$0.50
▲(0.00% Upside)
The overall stock score is primarily influenced by the mixed financial performance, with strong revenue growth but weak profitability. Positive technical indicators provide a bullish outlook, while the valuation is negatively impacted by the company's unprofitability despite a high dividend yield.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) vs. iShares MSCI Hong Kong ETF (EWH)

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Business Overview & Revenue Model

Company DescriptionHenan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) is a company engaged in the production and distribution of chemical products. The company specializes in hydrogenated chemicals, offering a range of products that serve various industrial applications. With a focus on quality and innovation, Henan Jinyuan supplies its products to both domestic and international markets, catering to industries such as pharmaceuticals, agrochemicals, and more.
How the Company Makes MoneyHenan Jinyuan Hydrogenated Chemicals Co., Ltd. generates revenue primarily through the sale of its hydrogenated chemical products. The company's key revenue streams include direct sales to industrial clients in sectors like pharmaceuticals and agrochemicals, as well as distribution partnerships that help expand its market reach. Additionally, Henan Jinyuan may engage in strategic collaborations or joint ventures to enhance its product offerings and access new markets, thereby contributing to its earnings.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Financial Statement Overview

Summary
The company is struggling with profitability and growth consistency. Despite some revenue recovery, profitability margins have worsened, leading to net losses. The balance sheet shows moderate stability but with increased leverage, and cash flow management has improved but remains inconsistent.
Income Statement
45
Neutral
The company has experienced significant volatility in revenue and profitability. The gross profit margin has declined from 12.4% in 2021 to 2.3% in 2024, indicating pressure on cost management. The net profit margin has deteriorated from 4.1% to negative, reflecting net losses in 2024. Revenue growth has been inconsistent, with a decrease of 10.4% from 2022 to 2023, followed by a 33.1% increase in 2024, but this did not translate to profitability. EBIT and EBITDA margins have also fallen, indicating operational inefficiencies.
Balance Sheet
60
Neutral
The balance sheet shows moderate financial stability with a debt-to-equity ratio of 0.34 in 2024, up from 0.22 in 2020, indicating increased leverage. The return on equity has turned negative in 2024, reflecting net losses. However, the equity ratio remains strong at 58.8% in 2024, suggesting a solid asset base supported by equity.
Cash Flow
55
Neutral
Cash flow performance has been mixed. Free cash flow turned positive in 2024, but overall growth has been inconsistent. The operating cash flow to net income ratio shows cash generation issues with net income losses. The free cash flow to net income ratio improved in 2024, indicating better cash management despite net losses.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.10B2.33B2.30B1.46B1.02B
Gross Profit71.64M148.80M285.51M142.80M91.41M
EBITDA77.03M163.47M266.82M176.34M113.14M
Net Income-16.04M54.92M121.38M59.14M24.48M
Balance Sheet
Total Assets1.68B1.66B1.06B971.94M969.90M
Cash, Cash Equivalents and Short-Term Investments352.62M300.71M106.16M73.03M78.34M
Total Debt338.27M262.97M219.16M96.89M125.83M
Total Liabilities584.85M535.95M334.98M400.14M447.76M
Stockholders Equity985.37M1.02B573.79M457.93M400.56M
Cash Flow
Free Cash Flow13.82M-43.95M199.74M44.27M-21.69M
Operating Cash Flow96.86M104.46M318.82M94.88M50.62M
Investing Cash Flow-268.86M-71.06M-150.12M-59.21M-72.31M
Financing Cash Flow2.49M204.95M-133.45M-40.95M20.11M

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.50
Price Trends
50DMA
0.44
Positive
100DMA
0.39
Positive
200DMA
0.43
Positive
Market Momentum
MACD
0.02
Positive
RSI
53.29
Neutral
STOCH
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2502, the sentiment is Neutral. The current price of 0.5 is below the 20-day moving average (MA) of 0.51, above the 50-day MA of 0.44, and above the 200-day MA of 0.43, indicating a neutral trend. The MACD of 0.02 indicates Positive momentum. The RSI at 53.29 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2502.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Peers Comparison

Overall Rating
UnderperformOutperform
Sector (56)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$945.36M9.802.51%8.33%-1.70%12.53%
68
Neutral
HK$225.60M14.876.12%2.22%-4.13%-35.11%
61
Neutral
7.33-1.60%4.22%30.77%-128.09%
57
Neutral
HK$696.28M-8.95%-3.09%-480.17%
56
Neutral
$6.41B9.61-29.56%6.32%10.97%-32.97%
49
Neutral
HK$763.30M55.38-1.16%7.63%2.49%-171.78%
48
Neutral
HK$72.62M
-60.57%53.71%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2502
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H
0.50
-0.10
-16.67%
HK:0377
China Huajun Group Limited
1.18
-0.09
-7.09%
HK:0301
SANVO Fine Chemicals Group Limited
1.51
0.51
51.00%
HK:2116
Jiangsu Innovative Ecological New Materials Ltd.
0.48
0.09
23.08%
HK:1986
Tsaker New Energy Tech Co., Limited
0.80
-0.02
-2.44%
HK:0408
Yip's Chemical Holdings
1.68
0.38
29.43%

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Corporate Events

Henan Jinyuan Approves AGM Resolutions, No Final Dividend for 2024
May 21, 2025

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced the successful approval of all resolutions at its annual general meeting held on May 21, 2025. The resolutions included the approval of the company’s financial reports, profit distribution plan, and the appointment of Deloitte Touche Tohmatsu as auditors. Notably, the company decided not to distribute a final dividend for the year ended December 31, 2024, which may impact shareholder returns.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 28, 2025